News Jounce set to make first biotech IPO of 2017 Massachusetts-based company will test the waters for biotech sector
News Circassia leads UK biotech funding success Three separate fund-raising rounds - headed by Circassia's £275 million placing and open offer - give a further indication of the revival in the
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
